Endothelial function and inflammation in coronary artery disease.

Evidence supports the central role of endothelium and inflammation in all phases of the atherosclerotic process. Clinical studies have shown their prognostic potential for the development of ischaemic events and for adverse outcome after acute coronary syndromes. Reduction in inflammatory levels and improving endothelial function by traditional and novel treatment strategies were associated with a proportional reduction in cardiovascular events. However, randomised controlled trials are required to explore further whether drugs targeting the inflammatory process and endothelial function will constitute a reasonable adjunctive treatment for patients with coronary artery disease.

[1]  K. Shimada,et al.  Multiple plaque rupture and C-reactive protein in acute myocardial infarction. , 2005, Journal of the American College of Cardiology.

[2]  G. Smith,et al.  Endothelial Dysfunction in Childhood Infection , 2005, Circulation.

[3]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[4]  Imran Awan,et al.  Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.

[5]  C. Tsioufis,et al.  Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[6]  C. Stefanadis,et al.  Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. , 2004, International journal of cardiology.

[7]  C. Tsioufis,et al.  Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. , 2003, Atherosclerosis.

[8]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[9]  A. Quyyumi,et al.  Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction , 2002, Circulation.

[10]  O. Raitakari,et al.  Obesity affects myocardial vasoreactivity and coronary flow response to insulin. , 2002, Obesity research.

[11]  T. Meinertz,et al.  Zytokine in der Pathogenese der Atherosklerose , 2002, Deutsche medizinische Wochenschrift.

[12]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[13]  E J Topol,et al.  Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.

[14]  J. Deanfield,et al.  Functions of the healthy endothelium. , 2001, Coronary artery disease.

[15]  C. Stefanadis,et al.  Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty. , 2001, International journal of cardiology.

[16]  D. Tousoulis,et al.  Vascular cell adhesion molecule‐1 and intercellular adhesion molecule‐1 serum level in patients with chest pain and normal coronary arteries (syndrome X) , 2001, Clinical cardiology.

[17]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[18]  Peter Søgaard,et al.  Electromechanical Mapping for Detection of Myocardial Viability in Patients With Ischemic Cardiomyopathy , 2001, Circulation.

[19]  C. Stefanadis,et al.  The Impact of Risk Factors for Atherosclerosis on the Vasomotor Effects of Inhibition of Nitric Oxide Synthesis in Patients with Normal Angiograms , 2000, Cardiology.

[20]  James T. Willerson,et al.  Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.

[21]  S. Fichtlscherer,et al.  Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.

[22]  S. Bhakdi,et al.  Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[23]  G. Kajiyama,et al.  Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. , 1999, Circulation.

[24]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[25]  S. Hazen,et al.  Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.

[26]  M. Pfeffer,et al.  Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. , 1998, Circulation.

[27]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[28]  J. Deanfield,et al.  Endothelial dysfunction late after Kawasaki disease. , 1996, Circulation.

[29]  D. Celermajer,et al.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.

[30]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[31]  J. Mehta,et al.  Neutrophil function in ischemic heart disease. , 1989, Circulation.

[32]  G. Gabbiani,et al.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.

[33]  G. Striker,et al.  Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. , 1981, The Journal of clinical investigation.

[34]  D. Panagiotakos,et al.  Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. , 2004, American heart journal.